HIV-1 evolution driven by intracellular defenses
HIV-1进化由细胞内防御驱动
基本信息
- 批准号:7190033
- 负责人:
- 金额:$ 36.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAnti-Retroviral AgentsAntiviral AgentsBinding SitesBiological AssayBoxingCellsComplementary DNACytidineCytidine DeaminaseDeaminaseDeaminationDinucleoside PhosphatesDrug resistanceEnzymesEventEvolutionFluorescenceGene SilencingGenomeHIVHIV-1IndividualInduced MutationInfectionMapsMediatingMutagenesisMutationNucleotidesNumbersPathogenesisPathogenicityPatternPeripheral Blood Mononuclear CellPharmaceutical PreparationsPlayPolymerasePropertyProteinsProvirusesRNA-Directed DNA PolymeraseRateResistanceRetroviridaeReverse TranscriptionRoleStructureTestingVariantViralVirusbasefitnessin vivomutantpressurepreventresearch studyvif Gene Productsvif Genes
项目摘要
Retroviruses have devised a number of strategies to evade cellular mechanisms aimed at preventing retroviral infection.
HIV-1 expressesVif, a protein that counteracts the antiviral activity of the cytidine deaminases APOBEC3G and APOBEC3F.
The nucleotide composition of the HIV-1 genome suggests, however, that protection from host-mediated viral cDNA
deamination may not be absolute. In preliminary studies, we showed that vif genes encoding proteins that fail to degrade
APOBEC3G, APOBEC3F or both can be detected in vivo. The loss of Vif function was mapped to single nucleotide
substitutions. These studies indicate that natural variation in Vif function may profoundly impact the extent and direction of
viral sequence evolution within HIV-1 infected individuals.
The experiments proposed herein will determine the extent to which host mechanisms aimed to prevent retroviral
infection, in fact, contribute to viral diversification and pathogenesis. We will analyze the fitness of viruses expressing Vif
proteins that are closely related but differ in their ability to neutralize APOBEC3G or APOBEC3F activities. We will also test if
variation in Vif function may be beneficial for viral adaptation under certain circumstances (e.g., in the presence of
antiretroviral drugs) by determining whether cytidine deamination by APOBEC3G or APOBEC3F selects for certain drug
resistance mutations. The pattern of hypermutations associated with partial protection from cytidine deamination will be
correlated to HIV fitness. Since APOBEC3 enzymes induce hypermutations in different dinucleotide contexts the
understanding of how activity against one enzyme but not the other is maintained is relevant for viral evolution. We will
conduct structure function studies to determine whether domains other than the Vif SOCS box motif are necessary and
essential for Vif mediated specific neutralization of APOBEC3 enzymes. Finally, we will assess the impact of reverse
transcription and APOBECS-driven mutagenesis on loss of Vif function. We will determine the rate of Vif inactivation as
result of either reverse transcriptase or cytidine deamination induced mutations on a single cell level using assays based on
fluorescence tagged APOBEC3G degradation. Variation in Vif function may influence the pathogenicity of HIV-1 by rendering
its genome more or less resistant to deaminase activity and these studies have the potential to reveal how Vif mediated
protection from cytidine deamination is modulated in vivo.
逆转录病毒已经设计了许多策略来逃避旨在预防逆转录病毒感染的细胞机制。
HIV-1表达Vif,一种抵消胞苷脱氨酶APOBEC 3G和APOBEC 3F的抗病毒活性的蛋白质。
然而,HIV-1基因组的核苷酸组成表明,
脱氨基作用可能不是绝对的。在初步研究中,我们发现vif基因编码的蛋白质不能降解
可以在体内检测APOBEC 3G、APOBEC 3F或两者。Vif功能的缺失定位于单核苷酸
替代品这些研究表明,Vif功能的自然变异可能会深刻影响细胞凋亡的程度和方向。
HIV-1感染者体内的病毒序列进化。
本文提出的实验将确定宿主机制旨在防止逆转录病毒的程度
事实上,感染有助于病毒多样化和致病性。我们将分析表达Vif的病毒的适应性
与APOBEC 3G或APOBEC 3F活性密切相关但在中和APOBEC 3G或APOBEC 3F活性的能力上不同的蛋白质。我们还将测试
Vif功能的变化在某些情况下可能有利于病毒适应(例如,存在下
通过确定APOBEC 3G或APOBEC 3F对胞苷脱氨基作用是否选择某些药物
耐药突变与胞苷脱氨基作用的部分保护相关的超突变模式将是
与艾滋病病毒适应性相关由于APOBEC 3酶在不同的二核苷酸背景下诱导超突变,
了解如何维持对一种酶而不是另一种酶的活性与病毒进化有关。我们将
进行结构功能研究以确定Vif SOCS盒基序以外的结构域是否是必需的,
对于Vif介导的APOBEC 3酶的特异性中和是必需的。最后,我们将评估逆转的影响。
转录和APOBECS驱动的突变对Vif功能丧失的影响。我们将确定Vif失活率,
逆转录酶或胞苷脱氨基诱导的突变在单细胞水平上的结果,使用基于
荧光标记的APOBEC 3G降解。Vif功能的变化可能通过使HIV-1的致病性降低而影响HIV-1的致病性。
其基因组或多或少地抵抗脱氨酶活性,这些研究有可能揭示Vif如何介导
胞苷脱氨基保护在体内被调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Viviana A Simon其他文献
Viviana A Simon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Viviana A Simon', 18)}}的其他基金
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
了解抗体反应并定义地方性和大流行性冠状病毒株保护的相关性
- 批准号:
10549479 - 财政年份:2023
- 资助金额:
$ 36.16万 - 项目类别:
Dissecting the drivers of persistent SARS-CoV-2 infections
剖析 SARS-CoV-2 持续感染的驱动因素
- 批准号:
10736007 - 财政年份:2023
- 资助金额:
$ 36.16万 - 项目类别:
Preventing CD4+ T memory cells from becoming HIV reservoirs
防止 CD4 T 记忆细胞成为 HIV 储存库
- 批准号:
9914204 - 财政年份:2018
- 资助金额:
$ 36.16万 - 项目类别:
Targeting HIV persistence in CD4+ T memory stem cells
靶向 CD4 T 记忆干细胞中的 HIV 持久性
- 批准号:
9321252 - 财政年份:2016
- 资助金额:
$ 36.16万 - 项目类别:
HTLV-1 antagonists of HIV restriction factors
HIV限制因子的HTLV-1拮抗剂
- 批准号:
8651884 - 财政年份:2013
- 资助金额:
$ 36.16万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 36.16万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 36.16万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 36.16万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 36.16万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 36.16万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 36.16万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 36.16万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 36.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 36.16万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 36.16万 - 项目类别:














{{item.name}}会员




